Track topics on Twitter Track topics that are important to you
RiboTargets is a privately owned pharmaceutical company that specialises in anti-infective research and development. Its therapeutic interests include antibacterial and antiviral agents (including HIV and Hepatitis C). The company has developed a unique computational screening platform technology RiboDock® which supports the rapid and effective generation of lead compounds from target structures. RiboDock® is the only computational screening platform capable of screening against both proteins and nucleic acids.
Granta Park Abington
Phone: 01223 895555
Fax: 01223 895556
RiboTargets is a privately owned pharmaceutical company that specialises in anti-infective research and development. Its therapeutic interests include antibacterial and antiviral agents (including HIV...
We have published hundreds of RiboTargets news stories on BioPortfolio along with dozens of RiboTargets Clinical Trials and PubMed Articles about RiboTargets for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of RiboTargets Companies in our database. You can also find out about relevant RiboTargets Drugs and Medications on this site too.
AIDS and HIV
AIDS; Acquired Immune Deficiency Syndrome. HIV; Human Immunodeficiency Virus HIV infection causes AIDS. HIV infection also causes the production of anti-HIV antibodies, which forms the test for HIV in patients. People who have the HIV antibodies are ...
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...